# Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer

> **NCT00104715** · PHASE3 · COMPLETED · sponsor: **UNICANCER** · enrollment: 385 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** antiandrogen therapy
- **DRUG:** docetaxel
- **DRUG:** goserelin acetate
- **PROCEDURE:** orchiectomy

## Key facts

- **NCT ID:** NCT00104715
- **Lead sponsor:** UNICANCER
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10-18
- **Primary completion:** 2011-12-04
- **Final completion:** 2015-12-15
- **Target enrollment:** 385 (ACTUAL)
- **Last updated:** 2021-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00104715

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00104715, "Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT00104715. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*